Savant Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294K Sell
26,930
-5,606
-17% -$61.5K ﹤0.01% 1939
2026
Q2
$324K Buy
32,536
+17,654
+119% +$197K ﹤0.01% 1453
2026
Q1
$161K Buy
14,882
+1,572
+12% +$13.5K ﹤0.01% 1443
2025
Q4
$81.3K Buy
13,310
+1,598
+14% +$9.5K ﹤0.01% 1344
2025
Q3
$60.7K Buy
11,712
+1,127
+11% +$6.48K ﹤0.01% 1297
2025
Q2
$62.8K Sell
10,585
-1,550
-13% -$9.33K ﹤0.01% 1216
2025
Q1
$100K Buy
+12,135
New +$102K ﹤0.01% 1038
2024
Q3
– Sell
-17,251
Closed -$179K – 1451
2024
Q2
$179K Buy
+17,251
New +$189K ﹤0.01% 1148

Other funds holding PTEN

Savant Capital's PTEN Position: Q3 2026 in Review

Savant Capital reduced its Patterson-UTI (PTEN) stake by 17% in Q3 2026, selling an estimated $61.5K and leaving 26,930 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Savant Capital first reported a position in PTEN in Q2 2024 and has held it in 8 quarters since. The position peaked at $324K in Q2 2026. 443 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.

  • Savant Capital held 26,930 shares of Patterson-UTI worth $294K as of Q3 2026.
  • Savant Capital sold 5,606 Patterson-UTI shares in Q3 2026, an estimated $61.5K.
  • Patterson-UTI made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #1939 holding.
  • Savant Capital first reported a position in Patterson-UTI in Q2 2024 and has held it in 8 quarters since.
  • Savant Capital's Patterson-UTI position peaked at $324K in Q2 2026.
  • 443 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.

Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.